Clinical Trial Update: Ultra Hypofractionnated Radiotherapy With HDR Brachytherapy Boost. [NA]

View source ↗

Summary

A clinical trial is recruiting to evaluate ultra hypofractionated radiotherapy with an HDR brachytherapy boost for localized prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: CHU de Quebec-Universite Laval | Conditions: Prostate Cancer, Radiotherapy Side Effect | NA | Status: RECRUITING